Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study.
Frontiers in oncology（2023）
摘要
As compared to NCT, the NICT could significantly increase the proportions of patients with pCR and MPR without increasing the operation-related bleeding and operation time.
更多查看译文
关键词
neoadjuvant chemotherapy,neoadjuvant immunochemotherapy,non-small cell lung cancer,pathological response,real world study
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要